title: The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.
abstract: We describe the effect of the proteasome specific inhibitor lactacystin on the metabolic stability of influenza nucleoprotein (NP) and on the generation of antigens presented by human and murine class I molecules of the major histocompatibility complex to cytotoxic T lymphocytes (CTL). We show that cells treated with lactacystin fail to present influenza antigens to influenza-specific CTL, but retain the capacity to present defined epitopes expressed as peptides intracellularly by recombinant vaccinia viruses. This block in antigen presentation can be overcome by expressing the viral protein within the lumen of the endoplasmic reticulum, confirming the specificity of lactacystin for cytosolic proteases. We also show that the effect of lactacystin on antigen presentation correlates with the block of breakdown of a rapidly degraded form of the influenza NP linked to ubiquitin. These results demonstrate that proteasome-dependent degradation plays an important role in the cytosolic generation of CTL epitopes.
authors.affiliation: Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB. vcerundo@worf.molbiol.ox.ac.uk
authors.forename: V
authors.initials: V
authors.lastname: Cerundolo
authors.forename: A
authors.initials: A
authors.lastname: Benham
authors.forename: V
authors.initials: V
authors.lastname: Braud
authors.forename: S
authors.initials: S
authors.lastname: Mukherjee
authors.forename: K
authors.initials: K
authors.lastname: Gould
authors.forename: B
authors.initials: B
authors.lastname: Macino
authors.forename: J
authors.initials: J
authors.lastname: Neefjes
authors.forename: A
authors.initials: A
authors.lastname: Townsend
mesh_terms: D000111:Acetylcysteine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D000938:Antigen-Presenting Cells / Q000502:physiology; D000956:Antigens, Viral / Q000276:immunology; D002478:Cells, Cultured; D003546:Cysteine Endopeptidases / Q000502:physiology*; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology*; D003600:Cytosol / Q000201:enzymology; D000939:Epitopes; D006183:H-2 Antigens / Q000276:immunology; D006801:Humans; D007976:Leupeptins / Q000276:immunology; D051379:Mice; D009097:Multienzyme Complexes / Q000502:physiology*; D019590:Nucleocapsid Proteins; D009698:Nucleoproteins; D009975:Orthomyxoviridae / Q000276:immunology; D010455:Peptides / Q000276:immunology; D046988:Proteasome Endopeptidase Complex; D015398:Signal Transduction; D013602:T-Lymphocytes, Cytotoxic / Q000502:physiology*; D014616:Vaccinia virus / Q000276:immunology; D014758:Viral Core Proteins / Q000276:immunology
chemical_list: D000956:Antigens, Viral; D015853:Cysteine Proteinase Inhibitors; D000939:Epitopes; D006183:H-2 Antigens; D007976:Leupeptins; D009097:Multienzyme Complexes; D019590:Nucleocapsid Proteins; D009698:Nucleoproteins; D010455:Peptides; D014758:Viral Core Proteins; C063261:acetylleucyl-leucyl-norleucinal; C067713:lactacystin; D003546:Cysteine Endopeptidases; D046988:Proteasome Endopeptidase Complex; D000111:Acetylcysteine